(1612–1632) Vasculitis – Non-ANCA-Associated & Related Disorders Poster II

Monday, October 27, 2025

10:30 AM - 12:30 PM Central Time

Location: Hall F1

CE: 0.00

Presentations:

10:30 AM - 12:30 PM Central Time

A Systematic Literature Review to Inform the 2025 EULAR Recommendations for Management of Polymyalgia Rheumatica and Large Vessel Vasculitis: Management of Disease Including Relapse and Complications
Abstract Poster Presenter: Mrinalini Dey, MRCP, MA, MBBCH – Centre for Rheumatic Diseases, King's College London
10:30 AM - 12:30 PM Central Time

A Systematic Literature Review to Inform the EULAR Recommendations for the Management of Polymyalgia Rheumatica and Large Vessel Vasculitis: Focus on Referral and Diagnosis
Abstract Poster Presenter: Alice Bartoletti, MD – ASST Gaetano Pini CTO
10:30 AM - 12:30 PM Central Time

Characterization of non-GCA, non-Takayasu Aortitis in a Single Health System Cohort
Abstract Poster Presenter: Nuzhat Batool, MBBS – NYU Grossman Long Island School of Medicine
10:30 AM - 12:30 PM Central Time

Correlation Between Histopathological Findings and PET-CT Results in Patients With Inflammatory Aortitis
Abstract Poster Presenter: Guillem Verdaguer Faja, MD, -None- – Hospital de la Santa Creu i Sant Pau
10:30 AM - 12:30 PM Central Time

Defective CD4+ regulatory T cells in active Takayasu arteritis patients can be improved by efficiency treatment of tofacitinib
Abstract Poster Presenter: jing luo, MD (she/her/hers) – the first affiliated hospital of xi'an jiaotong university
10:30 AM - 12:30 PM Central Time

Disease activity status in Takayasu's arteritis influences the angiogenic potential of patient-derived endothelial cells
Abstract Poster Presenter: Luciana Yamamoto de Almeida, PhD, MSc – National Institutes of Health
10:30 AM - 12:30 PM Central Time

Evaluating Familiarity and Knowledge Gaps in Polymyalgia Rheumatica Among Public Health Professionals
Abstract Poster Presenter: Erik Stone, MA – Global Healthy Living Foundation
10:30 AM - 12:30 PM Central Time

Factor VIII as a Potential Biomarker of Disease Activity in Relapsing Polychondritis
Abstract Poster Presenter: Marcela Ferrada, MD – University of Maryland
10:30 AM - 12:30 PM Central Time

New Arterial Damage in Takayasu’s Arteritis
Abstract Poster Presenter: Tanaz Kermani, MD, MS – University of California Los Angeles
10:30 AM - 12:30 PM Central Time

PET/CT-Based Distribution of Arterial Involvement and Its Association With Clinical Outcomes in Takayasu Arteritis
Abstract Poster Presenter: Tokio Katakura, MD – Department of Rheumatology, Tohoku University Hospital
10:30 AM - 12:30 PM Central Time

Prevalence of Clinical and Laboratory Manifestations of Patients with Deficiency of Adenosine Deaminase 2 (DADA2): A Systematic Review and Meta-Analysis
Abstract Poster Presenter: Athanasios Vassilopoulos, MD – Brown University
10:30 AM - 12:30 PM Central Time

Real-World Effectiveness of Interleukin-6 Receptor Inhibitors Compared to Methotrexate in Steroid-Refractory Frail Patients with Polymyalgia Rheumatica
Abstract Poster Presenter: Stefano Fiore, MD – Sanofi Genzyme & Regeneron
10:30 AM - 12:30 PM Central Time

Short-Course Prednisone and Methotrexate in Polymyalgia Rheumatica: A Potential Therapeutic Approach
Abstract Poster Presenter: Edoardo Conticini – Università di Siena
10:30 AM - 12:30 PM Central Time

Switching From Reference Tocilizumab to Biosimilar in Giant Cell Arteritis: Effectiveness and Safety in a Multicenter Study of 38 Patients
Abstract Poster Presenter: Adrián Martín-Gutiérrez, -None- – Hospital Universitario Marques de Valdecilla, IDIVAL
10:30 AM - 12:30 PM Central Time

Systemic Immune-Inflammation Index Is Superior to Neutrophil-to-Lymphocyte Ratio for Assessing Disease Activity in Polymyalgia Rheumatica and Giant Cell Arteritis
Abstract Poster Presenter: Gaston Ghio, Sr, MD – Hospital Universitari Mutua de Terrassa
10:30 AM - 12:30 PM Central Time

Temporal Association Between Viral Positivity Rates and Kawasaki Disease Incidence at a Large Tertiary Center
Abstract Poster Presenter: Jessica Nguyen, MD, MEd – Cook Children's Medical Center
10:30 AM - 12:30 PM Central Time

The Association of Calprotectin with Vascular Injury and Remodeling in Clinically-Isolated Aortitis
Abstract Poster Presenter: Katarina Kmetova, PhD, MSc – Division of Rheumatology, University of Michigan, Ann Arbor, Michigan, USA
10:30 AM - 12:30 PM Central Time

Use of JAK inhibitors in patients with refractory Takayasu arteritis: A worldwide retrospective study
Abstract Poster Presenter: Fatma Alibaz-Oner, MD – MARMARA UNIVERSITY, SCHOOL OF MEDICINE, DEPARTMENT OF INTERNAL MEDICINE, DIVISION OF RHEUMATOLOGY
10:30 AM - 12:30 PM Central Time

Validation of the classification algorithm using the modified 2022 ACR/EULAR giant cell arteritis classification criteria and Japanese Takayasu arteritis diagnostic criteria
Abstract Poster Presenter: Takahiko Sugihara, MD, PhD – Toho University School of Medicine
10:30 AM - 12:30 PM Central Time

Window of opportunity with tocilizumab therapy in giant cell arteritis. Multicenter study of 471 patients of clinical practice
Abstract Poster Presenter: Adrián Martín-Gutiérrez, -None- – Hospital Universitario Marques de Valdecilla, IDIVAL
10:30 AM - 12:30 PM Central Time

A Delphi Exercise Informing the Development of Criteria to Measure Response to Treatment in Giant Cell Arteritis
Abstract Poster Presenter: Medha Soowamber, MD – Mount Sinai Hospital